Beacon View Vets Limited 12079621 false 2023-03-01 2024-02-29 2024-02-29 The principal activity of the company is the provision of veterinary services. Digita Accounts Production Advanced 6.30.9574.0 true 12079621 2023-03-01 2024-02-29 12079621 2024-02-29 12079621 core:RetainedEarningsAccumulatedLosses 2024-02-29 12079621 core:ShareCapital 2024-02-29 12079621 core:CurrentFinancialInstruments core:WithinOneYear 2024-02-29 12079621 core:Non-currentFinancialInstruments core:AfterOneYear 2024-02-29 12079621 bus:SmallEntities 2023-03-01 2024-02-29 12079621 bus:AuditExemptWithAccountantsReport 2023-03-01 2024-02-29 12079621 bus:FullAccounts 2023-03-01 2024-02-29 12079621 bus:SmallCompaniesRegimeForAccounts 2023-03-01 2024-02-29 12079621 bus:RegisteredOffice 2023-03-01 2024-02-29 12079621 bus:Director1 2023-03-01 2024-02-29 12079621 bus:Director2 2023-03-01 2024-02-29 12079621 bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 12079621 core:FurnitureFittings 2023-03-01 2024-02-29 12079621 core:LeaseholdImprovements 2023-03-01 2024-02-29 12079621 core:OfficeEquipment 2023-03-01 2024-02-29 12079621 core:PlantMachinery 2023-03-01 2024-02-29 12079621 countries:AllCountries 2023-03-01 2024-02-29 12079621 2023-02-28 12079621 2022-03-01 2023-02-28 12079621 2023-02-28 12079621 core:RetainedEarningsAccumulatedLosses 2023-02-28 12079621 core:ShareCapital 2023-02-28 12079621 core:CurrentFinancialInstruments core:WithinOneYear 2023-02-28 12079621 core:Non-currentFinancialInstruments core:AfterOneYear 2023-02-28 iso4217:GBP xbrli:pure

Registration number: 12079621

Beacon View Vets Limited

Annual Report and Unaudited Filleted Abridged Financial Statements

for the Year Ended 29 February 2024

 

Beacon View Vets Limited

Contents

Abridged Balance Sheet

1 to 2

Notes to the Unaudited Abridged Financial Statements

3 to 4

 

Beacon View Vets Limited

(Registration number: 12079621)
Abridged Balance Sheet as at 29 February 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

4

134,090

133,567

Current assets

 

Stocks

5

10,648

13,263

Debtors

408,448

259,803

Cash at bank and in hand

 

73,744

83,429

 

492,840

356,495

Creditors: Amounts falling due within one year

6

(313,690)

(213,159)

Net current assets

 

179,150

143,336

Total assets less current liabilities

 

313,240

276,903

Creditors: Amounts falling due after more than one year

7

(92,051)

(90,870)

Provisions for liabilities

(24,881)

(25,200)

Net assets

 

196,308

160,833

Capital and reserves

 

Called up share capital

200

200

Profit and loss account

196,108

160,633

Total equity

 

196,308

160,833

 

Beacon View Vets Limited

(Registration number: 12079621)
Abridged Balance Sheet as at 29 February 2024

For the financial year ending 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the Board on 17 October 2024 and signed on its behalf by:
 

Mr J T Willmot

Director

Dr C M Smith

Director

 

Beacon View Vets Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 29 February 2024

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
Eastry Surgery
High St
Eastry
Sandwich
CT13 0HE

These financial statements were authorised for issue by the Board on 17 October 2024.

2

Accounting policies

Statement of compliance

These abridged financial statements were prepared in accordance with Financial Reporting Standard 102 Section 1A 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover represents the amounts, excluding value added tax, derived from the provision of goods and services to customers during the year.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Short leasehold improvements

5% straight line

Office equipment

33% straight line

Fixtures and fittings

25% straight line

Plant and machinery

25% reducing balance

 

Beacon View Vets Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 29 February 2024

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 21 (2023 - 22).

4

Tangible assets

Total
£

Cost or valuation

At 1 March 2023

220,672

Additions

32,498

At 29 February 2024

253,170

Depreciation

At 1 March 2023

87,106

Charge for the year

31,974

At 29 February 2024

119,080

Carrying amount

At 29 February 2024

134,090

At 28 February 2023

133,567

Included within the net book value of land and buildings above is £Nil (2023 - £Nil) in respect of long leasehold land and buildings and £56,305 (2023 - £57,146) in respect of short leasehold land and buildings.
 

5

Stocks

2024
£

2023
£

Stock

10,648

13,263

6

Creditors: amounts falling due within one year

Creditors include bank loans secured over the property of £4,400 (2023 - £8,400).

7

Creditors: amounts falling due after more than one year

Creditors include bank loans secured over the property of £17,600 (2023 - £33,600).

Creditors include bank loans repayable by instalments of £39,277 (2023 - £23,646) due after more than five years.

8

Financial commitments, guarantees and contingencies

Amounts not provided for in the balance sheet

The total amount of financial commitments not included in the balance sheet is £422,100 (2023 - £448,900).